These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33817989)

  • 1. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas GD; Dimitroulas T
    Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Burmester GR
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S2. PubMed ID: 26536183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Not Available].
    Strangfeld A
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S3-4. PubMed ID: 26536188
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular Consequences of Autoimmune Rheumatic Diseases.
    Atzeni F; Nucera V; Gerratana E; Fiorenza A; Gianturco L; Corda M; Sarzi-Puttini P
    Curr Vasc Pharmacol; 2020; 18(6):566-579. PubMed ID: 31985379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
    Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
    Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to special theme: vascular comorbidity in the rheumatic diseases.
    Yelin E; Katz P
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):483. PubMed ID: 21452261
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V;
    Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.
    Kerkhof PLM; Khamaganova I
    Adv Exp Med Biol; 2018; 1065():489-509. PubMed ID: 30051403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular involvement in rheumatic diseases].
    Driazhenko IV
    Kardiologiia; 2005; 45(11):98-104. PubMed ID: 16353072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study.
    Mehta B; Pedro S; Ozen G; Kalil A; Wolfe F; Mikuls T; Michaud K
    RMD Open; 2019; 5(1):e000935. PubMed ID: 31245055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of musculoskeletal pain and rheumatic diseases in the southeastern region of Mexico. A COPCORD-based community survey.
    Alvarez-Nemegyei J; Peláez-Ballestas I; Sanin LH; Cardiel MH; Ramirez-Angulo A; Goycochea-Robles MV
    J Rheumatol Suppl; 2011 Jan; 86():21-5. PubMed ID: 21196595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Cardiovascular Risk in Patients with Rheumatic Disease.
    Ferguson LD; Sattar N; McInnes IB
    Med Clin North Am; 2021 Mar; 105(2):247-262. PubMed ID: 33589100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatology, a clinical overview.
    Whisler RL; Gray LS; Hackshaw KV
    Clin Podiatr Med Surg; 2002 Jan; 19(1):149-61, vii. PubMed ID: 11806162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to manage rheumatic and musculoskeletal diseases - Preface.
    Stamm T; Moe RH
    Best Pract Res Clin Rheumatol; 2020 Apr; 34(2):101568. PubMed ID: 32762938
    [No Abstract]   [Full Text] [Related]  

  • 17. Comorbid conditions in patients with rheumatic diseases: an update.
    Wasko MC
    Curr Opin Rheumatol; 2004 Mar; 16(2):109-13. PubMed ID: 14770094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction to the topic: organ manifestation of the underlying rheumatic disease and association with widespread diseases].
    Märker-Hermann E
    Z Rheumatol; 2006 Oct; 65(6):471. PubMed ID: 17006701
    [No Abstract]   [Full Text] [Related]  

  • 19. The fate of the patient with musculoskeletal disorders in Italy: an epidemiological insight.
    Cimmino MA; Salaffi F
    Clin Exp Rheumatol; 2007; 25(6):803-5. PubMed ID: 18173911
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular co-morbidity in rheumatic diseases.
    Turesson C; Jacobsson LT; Matteson EL
    Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.